ADMA BIOLOGICS, INC. ADMA Cash Flow

Adma biologics, inc. (ADMA)

CashFlow / Quarterly

Mar'20	Dec'19	Sep'19	Jun'19	Mar'19	Dec'18	Sep'18	Jun'18	Mar'18	Dec'17	Sep'17	Jun'17	Mar'17	Dec'16	Sep'16	Jun'16	Mar'16	Dec'15	Sep'15	Jun'15	Mar'15	Dec'14	Sep'14	Jun'14	Mar'14	Dec'13	Sep'13	Jun'13	Mar'13	Dec'12	Sep'12	Jun'12	Mar'12	Dec'11	Sep'11	Jun'11	Mar'11	Dec'10	Sep'10
CASH FLOWS FROM OPERATING ACTIVITIES:
NET LOSS
-19,245	-10,561	-11,438	-13,211	-13,067	-18,037	-15,135	-14,747	-17,822	-12,982	-15,202	-9,036	-6,536	-4,559	-4,331	-6,012	-4,612	-4,582	-5,102	-4,679	-3,605	-	-	-	-5,903	-4,701	-2,688	-4,895	-3,241	-2,251	-3,245	-1,206	-597	-8	-5	-2,387	-1,580	-5	-4
Adjustments to reconcile net loss to net cash used in operating activities:
Depreciation and amortization
788	828	818	806	805	923	847	845	829	1,461	836	277	118	117	117	116	118	117	117	117	117	96	54	48	48	51	54	60	43	41	48	46	45	53	54	56	54	-	-
Loss on disposal of fixed assets
-0	-180	-18	-8	-0	-108	-10	-2	0	-5	0	0	-4	0	0	0	0	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	1,933	0	-1,329	-605	-	-
Stock-based compensation
676	636	650	726	637	595	577	535	514	508	505	311	235	253	262	310	422	489	447	386	387	327	327	360	234	221	225	222	218	-	-	-	46	3	1	7	11	-	-
Gain on transfer of plasma center assets
0	-	0	0	11,527	-	0	0	0	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-
Warrant liability
-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	0	0	0	-67	30	14	34	-5	17	-2	-21	-36	0	0	0	0	-	-	-	-	-	-
Amortization of debt discount
429	460	379	95	244	295	283	269	255	225	181	184	190	194	188	160	133	131	127	48	46	38	34	32	28	24	23	22	20	2	0	0	0	556	0	47	136	-	-
Loss on extinguishment of debt
0	-	0	0	-9,962	-	0	0	0	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-
Amortization of deferred financing costs
-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	0	0	16	23	31	33	31	29	27	26	25	20	2	0	0	0	-	-	-	-	-	-
Payment-in-kind interest
-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	0	0	50	74	57	50	49	19	0	0	0	0	-	-	-	-	-	-	-	-	-	-
Amortization of license revenue
-35	-35	-35	-35	-35	-35	-35	-35	-35	-35	-35	-35	-35	-35	-35	-35	-35	-58	-31	-18	-18	-18	-18	-18	-18	-18	-18	-6	0	-	-	-	-	-	-	-	-	-	-
Changes in operating assets and liabilities:
Accounts receivable
3,637	-3,845	2,228	3,776	-82	-2,734	329	139	-222	2,380	-792	1,452	-178	-309	500	-117	19	-276	678	171	-32	-178	-241	319	484	256	-98	89	-287	22	158	-220	0	0	87	-13	-73	-	-
Inventories
-775	12,779	16,695	5,149	25	4,738	1,630	-191	-189	-790	268	-355	288	402	408	160	603	614	377	511	232	256	339	128	-684	463	289	-92	-258	255	-193	27	27	172	0	-349	-131	-	-
Prepaid expenses and other current assets
2,321	817	119	-452	289	460	-300	-271	652	-27	-329	866	432	-167	-156	-106	633	-155	-132	-214	469	-142	-109	-202	298	75	-143	-284	543	-81	-118	-120	369	-41	-35	57	13	-	-
Deposits and other assets
79	-3	14	60	-179	188	-3	-6	29	-240	248	472	2	0	0	0	0	-	-	-	-	0	0	20	-6	-725	-8	-54	195	-25	0	-90	0	-	0	0	90	-	-
Accounts payable
-22	214	2,171	1,308	-420	632	2,166	-2,617	-202	-2,416	3,465	423	1,339	-212	-344	657	377	-108	617	-235	-69	-672	104	-424	54	1,185	323	-220	320	167	99	282	-794	-52	136	-52	8	-	-
Accrued expenses
-1,930	-520	1,855	232	-762	-606	458	466	88	-663	-106	1,544	-160	560	220	-57	-306	18	555	-259	-514	680	314	-169	526	-19	89	76	-70	174	323	-49	-298	-4	-0	-1	11	-3	-3
Accrued interest
-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	0	114	-9	-31	-0	-81	45	-72	0	2	33	-1	0	0	1	-	210	188	176	-	-
Other current and non-current liabilities
-45	-	-46	-20	-70	-	-59	43	207	-	11	-7	-7	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-
Deferred rent liability
-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-7	-7	-7	-7	68	-5	-5	-5	-5	-5	-5	-5	-5	-5	-5	-5	-5	-5	-5	-8	-2	-	-
Net cash used in operating activities
-24,646	-19,652	-23,630	-18,623	-14,287	-18,793	-12,543	-14,908	-16,434	-13,358	-9,739	-8,775	-5,398	-3,613	-4,683	-4,804	-5,167	-4,078	-2,673	-4,446	-4,220	-2,902	-2,465	-4,296	-5,040	-2,959	-2,225	-2,626	-3,074	-1,807	-2,054	-1,043	-1,998	-12	-5	-540	-445	-9	-8
CASH FLOWS FROM INVESTING ACTIVITIES:
Sales of short-term investments
-	-	-	-	-	-	-	-	-	-	0	245	5,145	-	0	-3,673	3,673	-	-	-	-6,859	-	-	-	732	-	-	-	-	-	-	-	-	-	-	-	-	-	-
Purchase of short-term investments
-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-1,666	6	3,378	0	-	-	-	-	-	-	-	-	-	-	-	-	-	-
Purchase of short-term investments
-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	0	0	0	-	-	-	-	-	-	-	-	-	-
Purchase of property and equipment
2,074	1,594	1,971	135	110	819	230	497	549	2,009	569	92	3	10	5	40	17	-4	8	7	14	556	1,396	258	111	5	16	108	66	35	27	56	0	-	-	-	-	-	-
Proceeds from the sale of property and equipment
2	-	-	-	0	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-
Net cash provided by (used in) investing activities
-2,072	-1,594	-1,971	-135	-110	-819	-230	-497	-549	-2,009	-569	12,652	5,141	5,626	238	-8,616	3,655	5,400	4,157	-4,425	-6,873	1,110	-1,402	-4,369	620	-2,940	-16	-108	-66	-35	-27	-56	0	-0	0	0	0	-	-
CASH FLOWS FROM FINANCING ACTIVITIES:
Proceeds from Hercules note payable, net of fees
-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	5,000	0	0	4,850	0	0	0	1,000	3,906	0	0	0	-1,200	350	550	300	-	-
Principal payments on note payable
0	0	0	0	30,000	0	0	0	0	15,555	1,666	1,666	1,111	0	0	0	0	-	-	-	-	-	-	-	-	-	-	-	-	0	0	0	200	200	0	0	0	-	-
Payment of end of term fee
0	0	0	0	2,760	0	0	0	0	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-
Payment of debt refinancing fees
0	-	0	0	6,499	-	0	0	0	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-
Proceeds from issuance of note payable
12,500	0	0	27,500	45,000	0	0	0	0	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-
Payment of debt issuance costs
0	0	0	123	1,555	0	0	0	0	-	-	-	-	-	-	-	-	-	-	-	-	0	0	-28	58	-	0	0	0	-	-	-	-	-	-	-	-	-	-
Proceeds from issuance of common stock, net of offering expenses
88,704	0	0	48,397	0	-	-	-	-	-	-	-	-	-	-	-	-	0	-136	-69	10,463	0	0	0	0	-	-	-	-	0	0	0	17,287	0	0	0	0	-	-
Proceeds from the exercise of stock options
7	0	0	75	0	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-
Equity issuance costs
-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	357	28	-71	71	71	36	296	933	0	0	0	0	-	-
Payments on finance lease obligations
7	7	7	7	7	7	7	2	0	-12	4	4	4	3	3	3	3	3	3	3	3	3	3	3	3	2	2	2	2	1	2	2	2	2	2	2	2	-	-
Payments of leasehold improvement loan
-	-	-	-	-	0	10	4	4	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-
Contributed capital
-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	15	2	-	-	-	-
Net cash provided by financing activities
101,203	-7	-7	75,840	4,177	-0	-12	42,939	-4	50,374	-1,663	13,154	-1,115	-3	-198	17,044	-3	-59	-128	129	10,459	5,039	-49	16	4,788	26,669	-31	68	925	3,657	-38	-299	16,150	15	2	547	297	-	-
Net (decrease) increase in cash and cash equivalents
74,483	-21,254	-25,609	57,081	-10,220	-19,612	-12,786	27,534	-16,987	35,006	-11,972	17,031	-1,371	2,008	-4,643	3,624	-1,515	1,263	1,355	-8,742	-634	3,247	-3,917	-8,648	368	20,769	-2,273	-2,667	-2,215	1,815	-2,121	-1,398	14,152	2	-2	6	-147	-0	-8
Cash paid for interest
-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	328	319	217	465	324	223	225	230	106	107	108	105	61	-2	0	0	3	0	0	0	2	0	0
Conversion of notes payable and accrued interest into common stock
-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	0	0	262	-	0	0	0	-	-
Reclassification of equity issuance costs to additional paid-in capital
-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-421	0	0	421	-	0	0	0	-	-
Reclassification of equity issuance costs
-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	0	0	11	-	0	0	0	-	-	-	-	-	-	-	-	-	-	-	-	-	-
Accrued equity issuance costs
-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	3	-	-116	-65	219	38	-28	45	0	-	-	-	-	69	-25	-254	279	-	-	-	-	-	-
Warrants issued in connection with note payable
-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	182	0	0	219	0	0	0	0	-	-	-	-	-	-	-	-	-	-
End of term liability in connection with note payable
-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	0	0	0	26	106	0	0	0	-	-	-	-	-	-
Elimination of warrant liability
-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	0	0	0	408	-	0	0	0	-	-	-	-	-	-	-	-	-	-	-	-	-	-
Accrued equity issuance costs
-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	0	0	-	-
Stock issued to shell company
-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	0	0	0	0	-	-
Income taxes
-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	0	0	-	-	0	0